|
Unaudited Forward-Looking Statements Regarding Business Outlook | ||||||
|
(In millions, except per share data) | ||||||
|
| ||||||
|
Business Outlook |
|
Three Months Ending June 30, 2018 | ||||
|
|
|
GAAP Measure |
|
Non-GAAP Adjustments |
|
Non-GAAP Measure |
|
Gross margin |
|
58.5% |
|
1.0% |
|
59.5% |
|
|
|
|
|
|
|
|
|
Operating expenses |
|
$111 |
|
$25 |
|
$86 |
|
|
|
|
|
|
|
|
|
Effective tax rate |
|
0.0% |
|
11.0% |
|
11.0% |
|
|
|
|
|
|
|
|
|
Diluted earnings per share - low |
|
$0.23 |
|
$0.58 |
|
$0.81 |
|
|
|
|
|
|
|
|
|
Diluted earnings per share - high |
|
$0.29 |
|
$0.58 |
|
$0.87 |
|
Silicon Laboratories Inc. | |||
|
Condensed Consolidated Balance Sheets | |||
|
(In thousands, except per share data) | |||
|
(Unaudited) | |||
|
| |||
|
|
March 31,
|
|
December 30, 2017 |
|
Assets |
|
|
|
|
Current assets: |
|
|
|
|
Cash and cash equivalents |
$ 342,272 |
|
$ 269,366 |
|
Short-term investments |
417,867 |
|
494,657 |
|
Accounts receivable, net |
75,122 |
|
71,367 |
|
Inventories |
76,505 |
|
73,132 |
|
Prepaid expenses and other current assets |
64,555 |
|
39,120 |
|
Total current assets |
976,321 |
|
947,642 |
|
Property and equipment, net |
129,894 |
|
127,682 |
|
Goodwill |
288,227 |
|
288,227 |
|
Other intangible assets, net |
76,716 |
|
83,144 |
|
Other assets, net |
94,837 |
|
88,387 |
|
Total assets |
$1,565,995 |
|
$1,535,082 |
|
|
|
|
|
|
Liabilities and Stockholders' Equity |
|
|
|
|
Current liabilities: |
|
|
|
|
Accounts payable |
$ 50,068 |
|
$ 38,851 |
|
Deferred revenue and returns liability |
25,426 |
|
-- |
|
Deferred income on shipments to distributors |
-- |
|
50,115 |
|
Other current liabilities |
69,310 |
|
73,359 |
|
Total current liabilities |
144,804 |
|
162,325 |
|
Convertible debt |
345,049 |
|
341,879 |
|
Other non-current liabilities |
75,567 |
|
77,862 |
|
Total liabilities |
565,420 |
|
582,066 |
|
Commitments and contingencies |
|
|
|
|
Stockholders' equity: |
|
|
|
|
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued |
-- |
|
-- |
|
Common stock – $0.0001 par value; 250,000 shares authorized; 43,227 and 42,707 shares issued and outstanding at March 31, 2018 and December 30, 2017, respectively |
4 |
|
4 |
|
Additional paid-in capital |
98,396 |
|
102,862 |
|
Retained earnings |
904,160 |
|
851,307 |
|
Accumulated other comprehensive loss |
(1,985) |
|
(1,157) |
|
Total stockholders' equity |
1,000,575 |
|
953,016 |
|
Total liabilities and stockholders' equity |
$1,565,995 |
|
$1,535,082 |
